相关实验视频

Updated: May 5, 2026

A Hyperandrogenic Mouse Model to Study Polycystic Ovary Syndrome

A Hyperandrogenic Mouse Model to Study Polycystic Ovary Syndrome

Published on: October 2, 2018

类固醇类固醇揭示了当前降低危害模型的局限性

Timothy Piatkowski^1,2, Jason M Nagata³, Suzanne Nielsen⁴

¹Centre for Health Services Research and Centre for Community Health and Wellbeing, Faculty of Health, Medicine, and Behavioural Sciences, The University of Queensland, Brisbane, Queensland, Australia.

Addiction (Abingdon, England)

|March 11, 2026

概括

降低危害的策略必须适应类固醇类固醇 (AAS) 使用的独特风险,这些风险是慢性和基于器官的. 需要针对不同用户群体量身定制的方法,以确保基于证据的护理.

科学领域:

药理学药理学是指药理学的学科.
毒理学毒理学毒理学
公共卫生公共卫生

背景情况:

主要针对精神活性药物使用的急性风险而开发的降低危害模型,未能充分解决与类固醇类固醇 (AAS) 使用相关的慢性,累积和器官性伤害.
不同的药理学,用户类型和AAS用户缓慢发展的生理风险被当前的减少危害范式所掩盖.
现有的模型往往优先考虑注射风险,忽视了与口服AAS配方相关的更大的肝毒性和改问题.

研究的目的:

倡导扩展和调整降害模型,以满足使用AAS的个体的特定需求.
突出需要具有上下文相关的减少危害策略,考虑到不同吸毒人口的独特特征.
为AAS用户提供适应危害减轻方法的实际框架.

主要方法:

对跨越AAS药理学,各种管理途径,依赖轨迹和用户人口统计数据的证据进行了批判性审查.
对其他物质现有的减少危害策略的分析,确定可转移的教训.
开发实用模板,以适应减少危害的干预措施,包括结构化剂量和供应检查.

主要成果:

使用AAS存在慢性,累积和器官特定的健康风险,与其他药物相关的急性风险有很大不同.
与注射形式相比,口服AAS配方存在更高的肝毒性和改风险.
由于缺乏量身定制的方法,目前的减少危害的做法往往被错误地应用于AAS用户.

结论:

减少危害必须演变为具有上下文相关性和基于证据的,超越一般化模型.
类固醇类固醇 (AAS) 的使用作为一个案例研究,以适应减少危害的各种物质使用配置文件.
有效的适应需要整合以消费者为中心的工具,员工培训和同行支持,以满足AAS用户的特定需求.

关键词:

类固醇雄激素类固醇减少伤害减少伤害医疗保健服务医疗保健服务塑造形象和提高表现的药物提高了药物的表现.在注射中注射.管理的途径的管理路径.

更多相关视频

Author Spotlight: Developing a Rat Model for Weight-Bearing Intervention to Investigate Osteonecrosis of the Femoral Head

Author Spotlight: Developing a Rat Model for Weight-Bearing Intervention to Investigate Osteonecrosis of the Femoral Head

Published on: September 27, 2024

Establishment of Rat Models Mimicking Gender-affirming Hormone Therapies

Establishment of Rat Models Mimicking Gender-affirming Hormone Therapies

Published on: January 10, 2025

相关概念视频

The Two-State Receptor Model

The Two-State Receptor Model

The two-state receptor model explains a drug's interaction with receptors, such as G protein-coupled receptors and ligand-gated ion channels, to induce or inhibit a biological response. When no natural ligands are present, a receptor exists in an equilibrium of inactive (Ri) and active (Ra) conformations. The inactive form does not produce a response, while the active form generates a basal effect known as constitutive activity.
The binding affinity of a drug determines its interaction with...

Drug Abuse and Addiction: Pharmacological Phenomena

Drug Abuse and Addiction: Pharmacological Phenomena

Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not...

Agonism and Antagonism: Quantification

Agonism and Antagonism: Quantification

When drugs are administered, they can elicit either an agonist or antagonist effect on the body. Agonism occurs when a drug activates a specific receptor, triggering a biological response. On the other hand, antagonism happens when a drug binds to the same receptors but blocks their activation, thereby preventing a biological response.
To quantify these effects, researchers use a dose-response curve, which provides valuable information about the potency and efficacy of a drug. Potency refers to...

Drug Control Governance: Regulatory Bodies and Their Impact

Drug Control Governance: Regulatory Bodies and Their Impact

Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...

Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions

Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions

PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure...